FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

ADOPTING NEW TECHNOLOGIES Previous Volume 352:857-859 March 3, 2005 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

When percutaneous transluminal coronary angioplasty (PTCA) entered mainstream use in the early 1980s, it represented a suboptimal substitute for coronary-artery bypass grafting (CABG). Over time, however, the outcomes of PTCA improved, and the technique became a viable alternative to CABG, even in the treatment of patients with advanced coronary disease. Nevertheless, the extent of the diffusion of PTCA as compared with CABG varied widely among hospitals. Several years after the introduction of PTCA, traditional CABG surgery was faced with a new competitor — minimally invasive cardiac surgery. Although the less invasive technique had clear advantages for some types of patients, . . . [Full Text of this Article]

Source Information

Dr. Huckman is an assistant professor and Dr. Pisano a professor of business administration at Harvard Business School, Boston.

This article has been cited by other articles:

• Grilli, R., Guastaroba, P., Taroni, F. (2007). Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventions. CMAJ 176: 185-190 [Abstract] [Full Text]  
• Kavoussi, L. R., Nielsen, M., Solomon, S. B. (2006). Percutaneous Image-guided Urologic Procedures.. Radiology 239: 11-12 [Full Text]